Travaux scientifiques

Doç. Dr. Haluk Tarık Kani

114 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Serum Phoenixin-14 Levels in Inflammatory Bowel Disease

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9622605/v1 Texte intégral en libre accèsSource : OpenAlex

  2. Diagnostic Accuracy of Biopsy-Sparing Approaches in Adult Celiac Disease

    Journal of clinical gastroenterology, 2026

    DOI 10.1097/mcg.0000000000002348 PMID 41719444 Source : Europe PMC

  3. Metabolic dysfunction-associated steatotic liver disease in cushing's syndrome: a case controlled FibroScan study

    Journal of endocrinological investigation, 2026

    DOI 10.1007/s40618-026-02876-6 PMID 42090111 2 citations (Europe PMC) Source : Europe PMC

  4. The relationship between acromegaly and hepatic steatosis: insights from FibroScan imaging

    Journal of endocrinological investigation, 2026

    DOI 10.1007/s40618-025-02799-8 PMID 41719003 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  5. Validation and Reliability of the Turkish Version of the Inflammatory Bowel Disease-Disk in Patients with Inflammatory Bowel Disease

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2026

    DOI 10.5152/tjg.2026.26405 PMID 42909348 Texte intégral en libre accèsSource : Europe PMC

  6. The Impact of Fistulizing Disease, Treatment Modalities, and Clinical Activity on Health-Related Quality of Life in Crohn's Disease

    Digestive diseases and sciences, 2026

    DOI 10.1007/s10620-026-10135-0 PMID 42509398 Source : Europe PMC

  7. Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease

    Journal of Crohn s and Colitis, 2026

    DOI 10.1093/ecco-jcc/jjag129 PMID 42700386 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. Risk factors for stricture-related surgery in stricturing Crohn’s disease

    BMC Gastroenterology, 2026

    DOI 10.1186/s12876-026-04802-9 PMID 42014995 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  9. P0780 Effect of JAK inhibitors on extra-intestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease

    Journal of Crohn s and Colitis, 2026

    DOI 10.1093/ecco-jcc/jjaf231.961 Source : OpenAlex

  10. P0264 Proximal Diseaase Extension and Associated Risk Factors in Patients with Distal Ulcerative Colitis

    Journal of Crohn s and Colitis, 2026

    DOI 10.1093/ecco-jcc/jjaf231.445 Source : OpenAlex

  11. Beyond Adiposity: Lean Mass Phenotyping and Adipokine Interpretation in Pediatric Crohn’s Disease

    Digestive Diseases and Sciences, 2026

    DOI 10.1007/s10620-026-09681-4 PMID 41572113 Source : OpenAlex

  12. Efficacy and Safety of Vedolizumab and Ustekinumab Treatment in Anti-TNF-Exposed Inflammatory Bowel Disease Patients

    Journal of Enterocolitis, 2026

    DOI 10.14744/jenterocolitis.2026.80717 Texte intégral en libre accèsSource : OpenAlex

  13. Association Between Sleep Quality and Postcolonoscopy Pain

    The Turkish Journal of Gastroenterology, 2026

    DOI 10.5152/tjg.2026.26044 PMID 42080282 Texte intégral en libre accèsSource : OpenAlex

  14. Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study

    Inflammatory Bowel Diseases, 2026

    DOI 10.1093/ibd/izag126 PMID 42485228 Texte intégral en libre accèsSource : OpenAlex

  15. Carbon Footprint of Gastrointestinal Endoscopy: A Prospective Procedure-Level Environmental Assessment

    Cerrahpasa Medical Journal, 2026

    DOI 10.5152/cjm.2026.26067 Texte intégral en libre accèsSource : OpenAlex

  16. Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor–Related Colitis With Vedolizumab: A Case Report and Literature Review

    Journal of Enterocolitis, 2026

    DOI 10.14744/jenterocolitis.2026.36634 Texte intégral en libre accèsSource : OpenAlex

  17. Prevalence and Clinical Associations of Malnutrition and Sarcopenia Risk in Gastroenterology Inpatients: A Multicenter Cross-Sectional Study in Turkey

    Diagnostics, 2025

    DOI 10.3390/diagnostics15222935 PMID 41300959 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  18. Usefulness of Endoscopic Ultrasound Strain Elastography for Measuring Liver Stiffness and the Role of Blood Cytokeratin 18 Levels as a Surrogate Marker of Fibrosis

    Turkish Journal of Gastroenterology, 2025

    DOI 10.5152/tjg.2025.24070 PMID 41085150 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  19. What Constitutes a High-Quality Guideline: Exploring Consumers' Views

    United European gastroenterology journal, 2025

    DOI 10.1002/ueg2.70000 PMID 40019477 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  20. Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles

    Journal of clinical medicine, 2025

    DOI 10.3390/jcm14238539 PMID 41375842 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  21. DOP101 Maintaining remission after an episode of steroid-responsive Acute Severe Ulcerative Colitis: what is the best strategy?

    Journal of Crohn s and Colitis, 2025

    DOI 10.1093/ecco-jcc/jjae190.0140 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  22. P1015 Upadacitinib as a Rescue Therapy in Patients with Steroid- and Infliximab-Refractory Acute Severe Ulcerative Colitis: Real-Life Multicentre Results

    Journal of Crohn s and Colitis, 2025

    DOI 10.1093/ecco-jcc/jjae190.1189 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  23. P1067 Comparison of AZA-Related Pancreatitis and AZA-Related GI Intolerance Based on Demographic Factors, Clinical Variables and HLA DQA1/DRB1 Alleles

    Journal of Crohn s and Colitis, 2025

    DOI 10.1093/ecco-jcc/jjae190.1241 1 citation (OpenAlex) Source : OpenAlex

  24. P1109 Evaluation of patient-reported outcome measures (PROMs) of IBD patients who completed upadacitinib induction period

    Journal of Crohn s and Colitis, 2025

    DOI 10.1093/ecco-jcc/jjae190.1283 Source : OpenAlex

  25. P0562 Evaluation of the impact of fistulizing disease on quality of life in Crohn's disease

    Journal of Crohn s and Colitis, 2025

    DOI 10.1093/ecco-jcc/jjae190.0736 Texte intégral en libre accèsSource : OpenAlex

  26. P0480 Evaluating the risk factors of surgery and postoperative complications in stricturing Crohn’s Disease

    Journal of Crohn s and Colitis, 2025

    DOI 10.1093/ecco-jcc/jjae190.0654 Source : OpenAlex

  27. Assessing the Disease Activity in Crohn’s Disease, Nothing Is Enough Alone

    The Turkish Journal of Gastroenterology, 2025

    DOI 10.5152/tjg.2025.25519 PMID 41669937 Texte intégral en libre accèsSource : OpenAlex

  28. Are Cross-Sectional Imaging Modalities Enough for Sarcopenia Assessment?

    The Turkish Journal of Gastroenterology, 2024

    DOI 10.5152/tjg.2024.23425 PMID 38454279 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  29. Cannulation rates and technical performance evaluation of commericially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis

    Digestive and Liver Disease, 2024

    DOI 10.1016/j.dld.2023.02.022 PMID 37003844 9 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  30. High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease

    Nutrition in Clinical Practice, 2024

    DOI 10.1002/ncp.11125 PMID 38321633 5 citations (Europe PMC) Source : ORCID

  31. Is Sarcopenia More Than Just Low Body Mass?

    Inflammatory Bowel Diseases, 2024

    DOI 10.1093/ibd/izae286 PMID 39607858 1 citation (Europe PMC) Source : ORCID

  32. Predicting fibrosis progression in non-alcoholic fatty liver disease patients using the FAST Score: A paired biopsy study

    Hepatology Forum, 2024

    DOI 10.14744/hf.2023.2023.0021 PMID 38283271 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  33. Quality of clinical guidelines: It matters as it impacts patient care

    United European Gastroenterology Journal, 2024

    DOI 10.1002/ueg2.12606 PMID 38837304 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  34. Response to “Utility of SARC‐F for screening for sarcopenia in ulcerative colitis”

    Nutrition in Clinical Practice, 2024

    DOI 10.1002/ncp.11183 PMID 38944753 Source : OpenAlex

  35. Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B

    Turkish Journal of Gastroenterology, 2023

    DOI 10.5152/tjg.2022.22196 PMID 36445058 7 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  36. Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis

    Hepatology Forum, 2023

    DOI 10.14744/hf.2023.2023.0034 PMID 37822315 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  37. Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma

    Hepatology Forum, 2023

    DOI 10.14744/hf.2022.2022.0048 PMID 37250924 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  38. Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning

    Inflammatory Bowel Diseases, 2023

    DOI 10.1093/ibd/izac226 PMID 36382800 20 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  39. Practical guideline on obesity care in patients with gastrointestinal and liver diseases- Joint ESPEN/UEG guideline

    Clinical Nutrition, 2023

    DOI 10.1016/j.clnu.2023.03.021 PMID 37146466 24 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  40. RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy

    The Turkish Journal of Gastroenterology, 2023

    DOI 10.5152/tjg.2023.237002 PMID 36919837 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  41. Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey

    Digestive Diseases, 2023

    DOI 10.1159/000528070 PMID 36412565 8 citations (Europe PMC) Source : ORCID

  42. Young gastroenterologists angle: Friends of the UEG young talent group consensus statement on the structure of young gastroenterology sections

    United European Gastroenterology Journal, 2023

    DOI 10.1002/ueg2.12430 PMID 37357495 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  43. Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis

    Inflammatory Bowel Diseases, 2023

    DOI 10.1093/ibd/izac277 PMID 36702534 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  44. Performance Evaluation of Single-Use Duodenoscopes for Endoscopic Retrograde Cholangiopancreatography: A Systematic Review And Meta-Analysis

    Endoscopy, 2023

    DOI 10.1055/s-0043-1765252 Source : OpenAlex

  45. Class Distance Weighted Cross-Entropy Loss for Ulcerative Colitis Severity Estimation

    Lecture Notes in Computer Science, 2022

    DOI 10.1007/978-3-031-12053-4_12 40 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  46. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline

    United European Gastroenterology Journal, 2022

    DOI 10.1002/ueg2.12280 PMID 35959597 31 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  47. European guideline on obesity care in patients with gastrointestinal and liver diseases- Joint ESPEN/UEG guideline

    Clinical Nutrition, 2022

    DOI 10.1016/j.clnu.2022.07.003 PMID 35970666 37 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  48. Indications, functional and quality of life outcomes of new pouch creation during re-do ileal pouch anal anastomosis: A comparative study with existing pouch salvage

    Surgery (St Louis), 2022

    DOI 10.1016/j.surg.2021.06.026 PMID 34272046 6 citations (Europe PMC) Source : ORCID

  49. Presence of axial spondyloarthritis associated sacroiliitis and structural changes on MR enterography: A direct comparison with sacroiliac joint MRI

    Clinical Imaging, 2022

    DOI 10.1016/j.clinimag.2022.08.017 PMID 36152432 Source : ORCID

  50. Evaluation of spleen stiffness in healthy population: a vibration-controlled transient elastography study

    Journal of Health Sciences and Medicine, 2022

    DOI 10.32322/jhsm.1074776 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex